Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

ngsLD: evaluating linkage disequilibrium using genotype likelihoods.

Fox EA, Wright AE, Fumagalli M, Vieira FG.

Bioinformatics. 2019 Mar 23. pii: btz200. doi: 10.1093/bioinformatics/btz200. [Epub ahead of print]

PMID:
30903149
2.

Effect of food deprivation or short-term Western diet feeding on BDNF protein expression in the hypothalamic arcuate, paraventricular, and ventromedial nuclei.

Gilland KE, Fox EA.

Am J Physiol Regul Integr Comp Physiol. 2017 Apr 1;312(4):R611-R625. doi: 10.1152/ajpregu.00256.2016. Epub 2017 Feb 15.

3.

Reduced intestinal brain-derived neurotrophic factor increases vagal sensory innervation of the intestine and enhances satiation.

Biddinger JE, Fox EA.

J Neurosci. 2014 Jul 30;34(31):10379-93. doi: 10.1523/JNEUROSCI.1042-14.2014.

4.

Dystrophin is a tumor suppressor in human cancers with myogenic programs.

Wang Y, Marino-Enriquez A, Bennett RR, Zhu M, Shen Y, Eilers G, Lee JC, Henze J, Fletcher BS, Gu Z, Fox EA, Antonescu CR, Fletcher CD, Guo X, Raut CP, Demetri GD, van de Rijn M, Ordog T, Kunkel LM, Fletcher JA.

Nat Genet. 2014 Jun;46(6):601-6. doi: 10.1038/ng.2974. Epub 2014 May 4.

5.

NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML.

Adamia S, Bar-Natan M, Haibe-Kains B, Pilarski PM, Bach C, Pevzner S, Calimeri T, Avet-Loiseau H, Lode L, Verselis S, Fox EA, Galinsky I, Mathews S, Dagogo-Jack I, Wadleigh M, Steensma DP, Motyckova G, Deangelo DJ, Quackenbush J, Tenen DG, Stone RM, Griffin JD.

Blood. 2014 May 1;123(18):2816-25. doi: 10.1182/blood-2013-02-481507. Epub 2014 Feb 26.

6.

A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets.

Adamia S, Haibe-Kains B, Pilarski PM, Bar-Natan M, Pevzner S, Avet-Loiseau H, Lode L, Verselis S, Fox EA, Burke J, Galinsky I, Dagogo-Jack I, Wadleigh M, Steensma DP, Motyckova G, Deangelo DJ, Quackenbush J, Stone R, Griffin JD.

Clin Cancer Res. 2014 Mar 1;20(5):1135-45. doi: 10.1158/1078-0432.CCR-13-0956. Epub 2013 Nov 27.

7.

Loss of neurotrophin-3 from smooth muscle disrupts vagal gastrointestinal afferent signaling and satiation.

Fox EA, Biddinger JE, Baquet ZC, Jones KR, McAdams J.

Am J Physiol Regul Integr Comp Physiol. 2013 Dec;305(11):R1307-22. doi: 10.1152/ajpregu.00337.2013. Epub 2013 Sep 25.

8.

Next-generation cDNA screening for oncogene and resistance phenotypes.

Shindoh N, Yoda A, Yoda Y, Sullivan TJ, Weigert O, Lane AA, Kopp N, Bird L, Rodig SJ, Fox EA, Weinstock DM.

PLoS One. 2012;7(11):e49201. doi: 10.1371/journal.pone.0049201. Epub 2012 Nov 7.

9.

Mechanism of hyperphagia contributing to obesity in brain-derived neurotrophic factor knockout mice.

Fox EA, Biddinger JE, Jones KR, McAdams J, Worman A.

Neuroscience. 2013 Jan 15;229:176-99. doi: 10.1016/j.neuroscience.2012.09.078. Epub 2012 Oct 13.

10.

Vagal afferent controls of feeding: a possible role for gastrointestinal BDNF.

Fox EA.

Clin Auton Res. 2013 Feb;23(1):15-31. doi: 10.1007/s10286-012-0170-x. Epub 2012 Jun 21. Review.

PMID:
22717678
11.
12.

SLATE: virtualizing multiscale CT training.

Mishra S, Sharma KS, Lee SJ, Fox EA, Wang G.

J Xray Sci Technol. 2012;20(2):239-48. doi: 10.3233/XST-2012-0332. Erratum in: J Xray Sci Technol. 2012;20(3):383.

13.

Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation.

Weigert O, Kopp N, Lane AA, Yoda A, Dahlberg SE, Neuberg D, Bahar AY, Chapuy B, Kutok JL, Longtine JA, Kuo FC, Haley T, Salois M, Sullivan TJ, Fisher DC, Fox EA, Rodig SJ, Antin JH, Weinstock DM.

Cancer Discov. 2012 Jan;2(1):47-55. doi: 10.1158/2159-8290.CD-11-0208. Epub 2011 Dec 12.

14.

Treating diet-induced obesity: a new role for vagal afferents?

Fox EA.

Dig Dis Sci. 2012 May;57(5):1115-7. doi: 10.1007/s10620-012-2122-7. Epub 2012 Mar 22. No abstract available.

PMID:
22438205
15.

Cigarette smoking increases copy number alterations in nonsmall-cell lung cancer.

Huang YT, Lin X, Liu Y, Chirieac LR, McGovern R, Wain J, Heist R, Skaug V, Zienolddiny S, Haugen A, Su L, Fox EA, Wong KK, Christiani DC.

Proc Natl Acad Sci U S A. 2011 Sep 27;108(39):16345-50. doi: 10.1073/pnas.1102769108. Epub 2011 Sep 12.

16.

Development of the vagal innervation of the gut: steering the wandering nerve.

Ratcliffe EM, Farrar NR, Fox EA.

Neurogastroenterol Motil. 2011 Oct;23(10):898-911. doi: 10.1111/j.1365-2982.2011.01764.x. Epub 2011 Aug 18. Review.

17.

Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms.

Liu P, Cheng H, Santiago S, Raeder M, Zhang F, Isabella A, Yang J, Semaan DJ, Chen C, Fox EA, Gray NS, Monahan J, Schlegel R, Beroukhim R, Mills GB, Zhao JJ.

Nat Med. 2011 Aug 7;17(9):1116-20. doi: 10.1038/nm.2402.

18.

Outcome of older adults with cytogenetically normal AML (CN-AML) and FLT3 mutations.

Singh H, Asali S, Werner LL, DeAngelo DJ, Ballen KK, Amrein PC, Wadleigh M, Galinsky I, Neuberg DS, Fox EA, Stone RM, Attar EC.

Leuk Res. 2011 Dec;35(12):1611-5. doi: 10.1016/j.leukres.2011.05.032. Epub 2011 Jun 21.

19.

Perceived protein needs and measured protein intake in collegiate male athletes: an observational study.

Fox EA, McDaniel JL, Breitbach AP, Weiss EP.

J Int Soc Sports Nutr. 2011 Jun 21;8:9. doi: 10.1186/1550-2783-8-9.

20.

Comparison of autologous stem cell transplantation versus consolidation chemotherapy for patients with cytogenetically normal acute myeloid leukemia (CN-AML) and FLT3ITD.

Singh H, Werner LL, Asali S, DeAngelo DJ, Ballen KK, Amrein PC, Wadleigh M, Galinsky I, Wolpin B, Pidala J, Neuberg DS, Fox EA, Stone RM, Attar EC.

Am J Hematol. 2011 Jul;86(7):625-7. doi: 10.1002/ajh.22041. No abstract available.

21.

Attainment of complete/very good partial response following rituximab-based therapy is an important determinant to progression-free survival, and is impacted by polymorphisms in FCGR3A in Waldenstrom macroglobulinaemia.

Treon SP, Yang G, Hanzis C, Ioakimidis L, Verselis SJ, Fox EA, Xu L, Hunter ZR, Tseng H, Manning RJ, Patterson CJ, Sheehy P, Turnbull B.

Br J Haematol. 2011 Jul;154(2):223-8. doi: 10.1111/j.1365-2141.2011.08726.x. Epub 2011 May 12.

PMID:
21564078
22.

Mice deficient in brain-derived neurotrophic factor have altered development of gastric vagal sensory innervation.

Murphy MC, Fox EA.

J Comp Neurol. 2010 Aug 1;518(15):2934-51. doi: 10.1002/cne.22372.

23.

Meal parameters and vagal gastrointestinal afferents in mice that experienced early postnatal overnutrition.

Biddinger JE, Fox EA.

Physiol Behav. 2010 Aug 4;101(1):184-91. doi: 10.1016/j.physbeh.2010.04.011. Epub 2010 Apr 18.

24.

Smooth-muscle-specific expression of neurotrophin-3 in mouse embryonic and neonatal gastrointestinal tract.

Fox EA, McAdams J.

Cell Tissue Res. 2010 May;340(2):267-86. doi: 10.1007/s00441-010-0959-7. Epub 2010 Apr 13.

25.

Preparation of DNA from fixed, paraffin-embedded tissue.

Fox EA.

Curr Protoc Hum Genet. 2001 May;Appendix 3:Appendix 3I. doi: 10.1002/0471142905.hga03is08.

PMID:
18428225
26.

Factors regulating vagal sensory development: potential role in obesities of developmental origin.

Fox EA, Murphy MC.

Physiol Behav. 2008 Apr 22;94(1):90-104. doi: 10.1016/j.physbeh.2007.11.024. Epub 2007 Nov 22.

27.
28.

Ultrastructural evidence for communication between intramuscular vagal mechanoreceptors and interstitial cells of Cajal in the rat fundus.

Powley TL, Wang XY, Fox EA, Phillips RJ, Liu LW, Huizinga JD.

Neurogastroenterol Motil. 2008 Jan;20(1):69-79. Epub 2007 Sep 4.

PMID:
17931338
29.

Exon expression profiling reveals stimulus-mediated exon use in neural cells.

McKee AE, Neretti N, Carvalho LE, Meyer CA, Fox EA, Brodsky AS, Silver PA.

Genome Biol. 2007;8(8):R159.

30.

Increased natural killer cell expression of CD16, augmented binding and ADCC activity to rituximab among individuals expressing the Fc{gamma}RIIIa-158 V/V and V/F polymorphism.

Hatjiharissi E, Xu L, Santos DD, Hunter ZR, Ciccarelli BT, Verselis S, Modica M, Cao Y, Manning RJ, Leleu X, Dimmock EA, Kortsaris A, Mitsiades C, Anderson KC, Fox EA, Treon SP.

Blood. 2007 Oct 1;110(7):2561-4. Epub 2007 May 2.

31.

Genetic fixity in the human major histocompatibility complex and block size diversity in the class I region including HLA-E.

Romero V, Larsen CE, Duke-Cohan JS, Fox EA, Romero T, Clavijo OP, Fici DA, Husain Z, Almeciga I, Alford DR, Awdeh ZL, Zuñiga J, El-Dahdah L, Alper CA, Yunis EJ.

BMC Genet. 2007 Apr 12;8:14.

32.
33.

Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays.

George RE, Attiyeh EF, Li S, Moreau LA, Neuberg D, Li C, Fox EA, Meyerson M, Diller L, Fortina P, Look AT, Maris JM.

PLoS One. 2007 Feb 28;2(2):e255.

34.

Genome-wide analysis of estrogen receptor binding sites.

Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF, Wang Q, Bekiranov S, Sementchenko V, Fox EA, Silver PA, Gingeras TR, Liu XS, Brown M.

Nat Genet. 2006 Nov;38(11):1289-97. Epub 2006 Oct 1.

PMID:
17013392
35.

Activating mutations in NOTCH1 in acute myeloid leukemia and lineage switch leukemias.

Palomero T, McKenna K, O-Neil J, Galinsky I, Stone R, Suzukawa K, Stiakaki E, Kalmanti M, Fox EA, Caligiuri MA, Aster JC, Look AT, Ferrando AA.

Leukemia. 2006 Nov;20(11):1963-6. Epub 2006 Sep 28.

PMID:
17008890
36.

Vagaries of adipose tissue innervation.

Berthoud HR, Fox EA, Neuhuber WL.

Am J Physiol Regul Integr Comp Physiol. 2006 Nov;291(5):R1240-2. Epub 2006 Jul 20. No abstract available.

37.

Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays.

Beroukhim R, Lin M, Park Y, Hao K, Zhao X, Garraway LA, Fox EA, Hochberg EP, Mellinghoff IK, Hofer MD, Descazeaud A, Rubin MA, Meyerson M, Wong WH, Sellers WR, Li C.

PLoS Comput Biol. 2006 May;2(5):e41. Epub 2006 May 12.

38.

A genetic approach for investigating vagal sensory roles in regulation of gastrointestinal function and food intake.

Fox EA.

Auton Neurosci. 2006 Jun 30;126-127:9-29. Epub 2006 May 4. Review.

PMID:
16677865
39.
40.

Coming of age: steroid hormones of wild immature baboons (Papio cynocephalus).

Gesquiere LR, Altmann J, Khan MZ, Couret J, Yu JC, Endres CS, Lynch JW, Ogola P, Fox EA, Alberts SC, Wango EO.

Am J Primatol. 2005 Sep;67(1):83-100.

PMID:
16163714
41.
42.

Genomic mapping of RNA polymerase II reveals sites of co-transcriptional regulation in human cells.

Brodsky AS, Meyer CA, Swinburne IA, Hall G, Keenan BJ, Liu XS, Fox EA, Silver PA.

Genome Biol. 2005;6(8):R64. Epub 2005 Jul 15.

43.

Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1.

Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR, Fox EA, Silver PA, Brown M.

Cell. 2005 Jul 15;122(1):33-43.

44.

Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.

Ma PC, Jagadeeswaran R, Jagadeesh S, Tretiakova MS, Nallasura V, Fox EA, Hansen M, Schaefer E, Naoki K, Lader A, Richards W, Sugarbaker D, Husain AN, Christensen JG, Salgia R.

Cancer Res. 2005 Feb 15;65(4):1479-88.

45.

Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia.

Treon SP, Hansen M, Branagan AR, Verselis S, Emmanouilides C, Kimby E, Frankel SR, Touroutoglou N, Turnbull B, Anderson KC, Maloney DG, Fox EA.

J Clin Oncol. 2005 Jan 20;23(3):474-81.

PMID:
15659493
46.

Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF).

Lepourcelet M, Tou L, Cai L, Sawada J, Lazar AJ, Glickman JN, Williamson JA, Everett AD, Redston M, Fox EA, Nakatani Y, Shivdasani RA.

Development. 2005 Jan;132(2):415-27. Epub 2004 Dec 16.

47.

Intra-and interpopulational differences in orangutan (Pongo pygmaeus) activity and diet: implications for the invention of tool use.

Fox EA, van Schaik CP, Sitompul A, Wright DN.

Am J Phys Anthropol. 2004 Oct;125(2):162-74.

PMID:
15365982
48.

Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412.

Stone RM, DeAngelo DJ, Klimek V, Galinsky I, Estey E, Nimer SD, Grandin W, Lebwohl D, Wang Y, Cohen P, Fox EA, Neuberg D, Clark J, Gilliland DG, Griffin JD.

Blood. 2005 Jan 1;105(1):54-60. Epub 2004 Sep 2.

49.

Increased short-term food satiation and sensitivity to cholecystokinin in neurotrophin-4 knock-in mice.

Chi MM, Fan G, Fox EA.

Am J Physiol Regul Integr Comp Physiol. 2004 Nov;287(5):R1044-53. Epub 2004 Aug 5.

50.

Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML.

Jiang J, Paez JG, Lee JC, Bo R, Stone RM, DeAngelo DJ, Galinsky I, Wolpin BM, Jonasova A, Herman P, Fox EA, Boggon TJ, Eck MJ, Weisberg E, Griffin JD, Gilliland DG, Meyerson M, Sellers WR.

Blood. 2004 Sep 15;104(6):1855-8. Epub 2004 Jun 3.

Supplemental Content

Support Center